Huntington’s Disease

About Huntington's Disease

Huntington’s Disease is a genetic neurodegenerative disorder that affects the patient’s normal movement, cognition and behaviour. There are currently no effective marketed treatments for HD. There are significant development programmes for novel and advanced therapies to treat the disease, with a large number of pharmaceutical and biotechnology companies working in this indication.  IXICO is proud to be contributing to the work to find a treatment for this disease.

Huntington’s is a terrible disease with a huge unmet need, and patients and their families desperately want treatments that work.

Track record

  • Industry leading track record in image acquisition and analysis supporting HD clinical trials in all phases of drug development.

Science consultancy

  • In house science provides optimum solutions for delivery of advanced imaging and wearables data science.
  • Protocol consultation at early stage to support Regulatory pathway.

Collaboration

  • Collaboration with International Consortia, academic Institutions and global networks of Research Sites enables efficient and effective delivery of imaging and other data science.

The patient

  • Patient centricity: gaining insights into people affected by Huntington’s disease coupled with training and technology improves recruitment, retention and support to trial participants.